These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 778749)

  • 1. ["In vitro" effect of medium size molecules on lymphocyte proliferation (author's transl)].
    Navarro J; Touraine JL; Corre C; Traeger J
    Pathol Biol (Paris); 1976 Mar; 24(3):189-93. PubMed ID: 778749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of medium sized molecules from patients with renal failure on lymphocyte stimulation by phytohemagglutinin.
    Touraine JL; Navarro J; Corre C; Traeger J
    Biomedicine; 1975 Jun; 23(5):180-3. PubMed ID: 1191730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of middle molecules on immunological functions.
    Navarro J; Contreras P; Touraine JL; Freyria AM; Later R; Traeger J
    Artif Organs; 1981; 4 Suppl():76-81. PubMed ID: 7028006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractions of middle molecular weight responsible for immunodeficiency in malnourished and burnt patients.
    Gay G; Touraine JL; Touraine F; Freyria AM; Traeger J; Navarro J
    Artif Organs; 1981; 4 Suppl():71-5. PubMed ID: 6794551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uremic toxins. Effect of plasma fractions on the lymphoproliferative response in vitro].
    Samaniego MC; Nesse A; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(3):252-60. PubMed ID: 6545559
    [No Abstract]   [Full Text] [Related]  

  • 6. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
    Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
    Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietic inhibitors in uremic serum.
    Freedman MH; Grunberger T; Saunders EF
    Clin Invest Med; 1982; 5(4):237-40. PubMed ID: 7160111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.
    Raskova J; Ghobrial I; Czerwinski DK; Shea SM; Eisinger RP; Raska K
    Arch Intern Med; 1987 Jan; 147(1):89-93. PubMed ID: 3492183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of human monocytes and macrophages on lymphocyte proliferation.
    Passwell JH; Levanon M; Davidsohn J; Kohen F; Ramot B
    Immunology; 1982 Sep; 47(1):175-81. PubMed ID: 6956545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanism of action of D-penicillamine (DPA) on human lymphocytes (author's transl)].
    Feickert HJ; Schumacher K
    Arzneimittelforschung; 1980; 30(9):1480-3. PubMed ID: 7193012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an association of CD45 with 32,000-33,000 MW phosphoproteins on murine T and B lymphocytes.
    Altin JG; Pagler EB; Parish CR
    Immunology; 1994 Nov; 83(3):420-9. PubMed ID: 7835967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of lymphocytes in chronic renal failure: in vitro response to mitogens.
    Nanni Costa A; Feliciangeli G; Borgnino LC; Buscaroli A; Mosconi G; Scolari MP; Orsi C; Coli L; Jannelli S; Galanti S
    Life Support Syst; 1983; 1 Suppl 1():88-91. PubMed ID: 6336587
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte blastogenesis in patients receiving hemodialysis.
    Webel ML; Ritts RE; Briggs WA; Light JA
    Arch Intern Med; 1976 Jun; 136(6):682-7. PubMed ID: 1275624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of high molecular weight substances from CAPD dialysate on mouse bone marrow progenitor cells and lymphocyte transformation.
    Yang CL; Du XH; Wu H
    Chin Med J (Engl); 1994 Apr; 107(4):248-53. PubMed ID: 8088189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
    Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.